![]() |
|
|
Vol. 291, Issue 1, 409-415, October 1999
Brookhaven National Laboratory, Increases in dopamine concentration in limbic brain regions have
been postulated to underlie the reinforcing effects of psychostimulant drugs in laboratory animals. However, neither the qualitative nor the
quantitative relationship between drug-induced increases in brain
dopamine and the reinforcing effects of psychostimulant drugs have been
investigated in humans. Positron emission tomograph and
[11C]raclopride, a dopamine D2
receptor radioligand that competes with endogenous dopamine for
occupancy of the D2 receptors, were used to measure changes
in brain dopamine after different doses of i.v. methylphenidate in 14 healthy controls. In parallel, measures for self-reports of drug
effects were obtained to assess their relationship to
methylphenidate-induced changes in brain dopamine. The intensity of the
"high" induced by methylphenidate was significantly correlated with
the levels of released dopamine (r = 0.78, p < .001); subjects having the greatest increases
were those who perceived the most intense high. This relationship
remained significant after partialing out for dose and concentration of
methylphenidate in plasma. Furthermore, subjects for whom
methylphenidate did not increase dopamine did not perceive a high.
These results represent the first clear demonstration that
stimulant-induced high, a mood descriptor that reflects reinforcing
effects of drugs in humans, is associated with increases in brain
dopamine, and also that there is a quantitative relationship between
levels of D2 receptor occupancy by dopamine and the
intensity of the high.
0022-3565/99/2911-0409$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
W. K. Schiffer, C. N. B. Liebling, C. Reiszel, J. M. Hooker, J. D. Brodie, and S. L. Dewey Cue-Induced Dopamine Release Predicts Cocaine Preference: Positron Emission Tomography Studies in Freely Moving Rodents J. Neurosci., May 13, 2009; 29(19): 6176 - 6185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Evans, A D Lawrence, and A J Lees Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 267 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R.C. Daglish, T. M. Williams, S. J. Wilson, L. G. Taylor, C. B. Eap, M. Augsburger, C. Giroud, D. J. Brooks, J. S. Myles, P. Grasby, et al. Brain dopamine response in human opioid addiction The British Journal of Psychiatry, July 1, 2008; 193(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Sessa and D Nutt Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 Journal J Psychopharmacol, June 1, 2008; 22(4): 457 - 458. [PDF] |
||||
![]() |
J. A. den Boer, A.A.T. S. Reinders, and G. Glas Special Section: On Looking Inward: Revisiting the Role of Introspection in Neuroscientific and Psychiatric Research Theory Psychology, June 1, 2008; 18(3): 380 - 403. [Abstract] [PDF] |
||||
![]() |
M. R. Drew, E. H. Simpson, C. Kellendonk, W. G. Herzberg, O. Lipatova, S. Fairhurst, E. R. Kandel, C. Malapani, and P. D. Balsam Transient Overexpression of Striatal D2 Receptors Impairs Operant Motivation and Interval Timing J. Neurosci., July 18, 2007; 27(29): 7731 - 7739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gray, M. Punsoni, N. E. Tabori, J. T. Melton, V. Fanslow, M. J. Ward, B. Zupan, D. Menzer, J. Rice, C. T. Drake, et al. Methylphenidate Administration to Juvenile Rats Alters Brain Areas Involved in Cognition, Motivated Behaviors, Appetite, and Stress J. Neurosci., July 4, 2007; 27(27): 7196 - 7207. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ashton, P. Gallagher, and B. Moore The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder J Psychopharmacol, September 1, 2006; 20(5): 602 - 610. [Abstract] [PDF] |
||||
![]() |
A. L. Malizia The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology J Psychopharmacol, July 1, 2006; 20(4_suppl): 100 - 107. [Abstract] [PDF] |
||||
![]() |
N. D. Volkow and J. M. Swanson Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD Am J Psychiatry, November 1, 2003; 160(11): 1909 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pecina, B. Cagniard, K. C. Berridge, J. W. Aldridge, and X. Zhuang Hyperdopaminergic Mutant Mice Have Higher "Wanting" But Not "Liking" for Sweet Rewards J. Neurosci., October 15, 2003; 23(28): 9395 - 9402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tong, B. M. Ross, G. A. Schmunk, F. J. Peretti, K. S. Kalasinsky, Y. Furukawa, L. C. Ang, S. S. Aiken, D. J. Wickham, and S. J. Kish Decreased Striatal Dopamine D1 Receptor- Stimulated Adenylyl Cyclase Activity in Human Methamphetamine Users Am J Psychiatry, May 1, 2003; 160(5): 896 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Gusnard, J. M. Ollinger, G. L. Shulman, C. R. Cloninger, J. L. Price, D. C. Van Essen, and M. E. Raichle Persistence and brain circuitry PNAS, March 18, 2003; 100(6): 3479 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kelley and K. C. Berridge The Neuroscience of Natural Rewards: Relevance to Addictive Drugs J. Neurosci., May 1, 2002; 22(9): 3306 - 3311. [Full Text] [PDF] |
||||
![]() |
L. K. Tremblay, C. A. Naranjo, L. Cardenas, N. Herrmann, and U. E. Busto Probing Brain Reward System Function in Major Depressive Disorder: Altered Response to Dextroamphetamine Arch Gen Psychiatry, May 1, 2002; 59(5): 409 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Caine, S. S. Negus, N. K. Mello, S. Patel, L. Bristow, J. Kulagowski, D. Vallone, A. Saiardi, and E. Borrelli Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists J. Neurosci., April 1, 2002; 22(7): 2977 - 2988. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Bednarczyk Functional Imaging for the Monitoring of Clinical Outcomes of Pharmacotherapy Journal of Pharmacy Practice, August 1, 2001; 14(4): 298 - 307. [Abstract] [PDF] |
||||
![]() |
S. JAYANTHI, X. DENG, M. BORDELON, M. T. MCCOY, and J. L. CADET Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex FASEB J, August 1, 2001; 15(10): 1745 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Tomkins and E. M. Sellers Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence Can. Med. Assoc. J., March 1, 2001; 164(6): 817 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Gordon, L. Yao, Z. Jiang, C. S. Fishburn, S. Fuchs, and I. Diamond Ethanol Acts Synergistically with a D2 Dopamine Agonist to Cause Translocation of Protein Kinase C Mol. Pharmacol., January 1, 2001; 59(1): 153 - 160. [Abstract] [Full Text] |
||||
![]() |
C. L. Wyvell and K. C. Berridge Intra-Accumbens Amphetamine Increases the Conditioned Incentive Salience of Sucrose Reward: Enhancement of Reward "Wanting" without Enhanced "Liking" or Response Reinforcement J. Neurosci., November 1, 2000; 20(21): 8122 - 8130. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Volkow, G.-J. Wang, J. S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y.-S. Ding, S. J. Gatley, A. Gifford, and D. Franceschi Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain J. Neurosci., January 15, 2001; 21(2): RC121 - RC121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Knutson, C. M. Adams, G. W. Fong, and D. Hommer Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens J. Neurosci., August 15, 2001; 21(16): RC159 - RC159. [Abstract] [Full Text] [PDF] |
||||